Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bridging Radiation Prior to CAR T-Cell Infusion in Large B-Cell Lymphoma
NCT05800405Phase 1Recruiting
- Sponsor
- City of Hope
- Start
- Jul 2023
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in diffuse large B-cell lymphoma (DLBCL), sponsored by City of Hope. Primary endpoint: Proportion of participants completing planned radiation therapy. Started Jul 2023; status: recruiting.
02
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT05800405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05800405.